- Home
- GHRS vs ACEL Comparison
GHRS vs ACEL Comparison
Compare GHRS & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- ACEL
- Stock Information
- Founded
- GHRS 2018
- ACEL 2009
- Country
- GHRS Ireland
- ACEL United States
- Employees
- GHRS N/A
- ACEL 1500
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- ACEL Services-Misc. Amusement & Recreation
- Sector
- GHRS Health Care
- ACEL Consumer Discretionary
- Exchange
- GHRS Nasdaq
- ACEL Nasdaq
- Market Cap
- GHRS 960.2M
- ACEL 1.1B
- IPO Year
- GHRS 2021
- ACEL N/A
- Fundamental
- Price
- GHRS $14.38
- ACEL $12.86
- Analyst Decision
- GHRS Strong Buy
- ACEL Buy
- Analyst Count
- GHRS 8
- ACEL 1
- Target Price
- GHRS $30.63
- ACEL $16.00
- AVG Volume (30 Days)
- GHRS 353.0K
- ACEL 253.2K
- Earning Date
- GHRS 09-02-2025
- ACEL 08-05-2025
- Dividend Yield
- GHRS N/A
- ACEL N/A
- EPS Growth
- GHRS N/A
- ACEL N/A
- EPS
- GHRS N/A
- ACEL 0.49
- Revenue
- GHRS N/A
- ACEL $1,253,067,000.00
- Revenue This Year
- GHRS N/A
- ACEL $9.34
- Revenue Next Year
- GHRS N/A
- ACEL $4.61
- P/E Ratio
- GHRS N/A
- ACEL $26.27
- Revenue Growth
- GHRS N/A
- ACEL 6.28
- 52 Week Low
- GHRS $6.00
- ACEL $9.02
- 52 Week High
- GHRS $20.50
- ACEL $13.26
- Technical
- Relative Strength Index (RSI)
- GHRS 46.75
- ACEL 68.21
- Support Level
- GHRS $12.81
- ACEL $12.03
- Resistance Level
- GHRS $15.28
- ACEL $13.28
- Average True Range (ATR)
- GHRS 1.49
- ACEL 0.31
- MACD
- GHRS -0.41
- ACEL 0.04
- Stochastic Oscillator
- GHRS 20.60
- ACEL 77.20
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.